Biological Background of GNB2

GNB2 encodes the beta-2 subunit of heterotrimeric guanine nucleotide-binding proteins (G proteins), which are central mediators of intracellular signal transduction initiated by G-protein-coupled receptors (GPCRs). The GNB2 protein belongs to the WD-repeat protein superfamily and forms a stable beta-gamma dimer with various gamma subunits. This Gβγ complex plays a dual role: it anchors the inactive Gα subunit and, upon receptor activation, dissociates to modulate downstream effectors including adenylyl cyclase, phospholipase C, and ion channels.

GNB2 is ubiquitously expressed across mammalian tissues and has been implicated in processes such as cell proliferation, immune cell chemotaxis, and neuronal signaling. Dysregulation of GNB2 has been associated with cardiovascular disorders and certain cancers, making it a relevant target for translational research.

Protein Specifications and Quality Attributes

Recombinant Human GNB2 Protein (rp375095) is produced using recombinant expression technology to ensure consistent lot-to-lot reproducibility. Researchers should verify the following key quality attributes upon receipt and prior to use:

• Identity: Confirmed as human GNB2 by sequence or immunological verification.
• Purity: Assessed by SDS-PAGE or HPLC; target purity should be confirmed in the accompanying Certificate of Analysis (CoA).
• Endotoxin Level: Should meet thresholds appropriate for cell-based assays; refer to the CoA for lot-specific values.
• Formulation: Typically supplied in a physiologically compatible buffer; confirm formulation details on the product datasheet.
• Biological Activity: Functionality may be confirmed via protein–protein interaction assays or downstream signaling readouts.

Note: Specific numerical values for purity, concentration, and endotoxin content are lot-dependent. Always consult the Certificate of Analysis supplied with each shipment.

Reconstitution and Storage Protocol

Proper handling of Recombinant Human GNB2 Protein is essential to maintain protein integrity and ensure reproducible experimental results. Follow the guidelines below:

1. Reconstitution: If supplied in lyophilized form, briefly centrifuge the vial before opening. Reconstitute with sterile deionized water or the buffer specified in the product datasheet to achieve the recommended working concentration. Allow the protein to dissolve gently; avoid vigorous vortexing.
2. Working Aliquots: Prepare single-use aliquots immediately after reconstitution to minimize freeze-thaw cycles, which can lead to protein aggregation and loss of activity.
3. Short-Term Storage: Store at 4 °C for up to 1 week if the protein will be used promptly.
4. Long-Term Storage: Store at −20 °C or −80 °C as specified on the datasheet. Addition of a carrier protein (e.g., 0.1% BSA) may enhance stability during long-term storage.
5. Avoid Repeated Freeze-Thaw Cycles: Each additional freeze-thaw cycle risks reducing protein activity. Limit to no more than three cycles.

Always refer to the lot-specific datasheet and CoA for storage conditions validated by Aladdin Scientific quality control.

Research Applications

Recombinant Human GNB2 Protein is suitable for a range of in vitro and biochemical research applications, including but not limited to:

• Protein–Protein Interaction Studies: GNB2 is an established binding partner for Gγ subunits and Gα subunits. Pull-down assays and co-immunoprecipitation experiments can be performed to characterize interaction dynamics.
• Biochemical Reconstitution: GNB2 can be used in cell-free reconstitution systems to study Gβγ-effector coupling, such as interactions with GIRK channels or PI3Kγ.
• Enzyme-Linked Immunosorbent Assay (ELISA) Development: As a reference standard for quantification of endogenous GNB2 in biological samples.
• Structural Studies: Suitable as a component in biophysical studies including surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) to measure binding affinities.
• Drug Discovery Screening: Used as a tool protein to screen small-molecule modulators of Gβγ signaling.
• Western Blot Positive Control: Serves as a positive control in western blot experiments to validate antibody specificity.

Experimental Considerations and Troubleshooting

To obtain optimal results with Recombinant Human GNB2 Protein, researchers should consider the following practical points:

• Buffer Compatibility: Confirm that the reconstitution buffer is compatible with your downstream assay. Detergents, high salt concentrations, or reducing agents in the buffer may interfere with certain assay formats.
• Protein Aggregation: If turbidity or precipitation is observed, centrifuge at 10,000 × g for 5 minutes at 4 °C and use the supernatant. Aggregation may indicate improper storage or excessive freeze-thaw cycles.
• Low Signal in Interaction Assays: Ensure the Gβγ dimer is properly formed if reconstituting GNB2 with a Gγ subunit. Incomplete dimerization can reduce effector binding efficiency.
• Concentration Determination: Use a validated protein quantification method (e.g., BCA or Bradford assay) appropriate for the formulation buffer, as some buffer components may interfere with absorbance-based assays.
• Positive Controls: Include validated positive controls in each experiment to confirm assay performance independently of the test protein.